Matches in Wikidata for { <http://www.wikidata.org/entity/Q66042721> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q66042721 description "clinical trial" @default.
- Q66042721 description "ensayu clínicu" @default.
- Q66042721 description "klinisch onderzoek" @default.
- Q66042721 description "клінічне випробування" @default.
- Q66042721 name "Active Controlled Trial of CHF5993 Pressurized Metered-dose Inhaler ( pMDI) vs Symbicort®Turbuhaler® in Patients With Chronic Obstructive Pulmonary Disease ( COPD)" @default.
- Q66042721 name "Active Controlled Trial of CHF5993 Pressurized Metered-dose Inhaler" @default.
- Q66042721 type Item @default.
- Q66042721 label "Active Controlled Trial of CHF5993 Pressurized Metered-dose Inhaler ( pMDI) vs Symbicort®Turbuhaler® in Patients With Chronic Obstructive Pulmonary Disease ( COPD)" @default.
- Q66042721 label "Active Controlled Trial of CHF5993 Pressurized Metered-dose Inhaler" @default.
- Q66042721 prefLabel "Active Controlled Trial of CHF5993 Pressurized Metered-dose Inhaler ( pMDI) vs Symbicort®Turbuhaler® in Patients With Chronic Obstructive Pulmonary Disease ( COPD)" @default.
- Q66042721 prefLabel "Active Controlled Trial of CHF5993 Pressurized Metered-dose Inhaler" @default.
- Q66042721 P1132 Q66042721-1AF9AAA4-918F-427C-AD12-05B40DE2617C @default.
- Q66042721 P1476 Q66042721-DF48B193-4876-4980-981B-D4DD0FF7C027 @default.
- Q66042721 P17 Q66042721-FAEC0428-A1CC-4106-BF2E-C6A0C4FA77D4 @default.
- Q66042721 P1813 Q66042721-AF7BADE9-0E5A-4A6B-8D91-FEEB7C4EBC12 @default.
- Q66042721 P2899 Q66042721-963C8997-CE98-46A3-9D3C-FDC7EDA2DE8D @default.
- Q66042721 P3098 Q66042721-3D35B410-18B4-45D4-8902-EF5FCD75CB28 @default.
- Q66042721 P31 Q66042721-8544B133-5A4D-4238-A0AC-EA726193A167 @default.
- Q66042721 P4844 Q66042721-15C7B9DB-E298-4C7B-ABCB-66E84E3775A6 @default.
- Q66042721 P4844 Q66042721-7D87E114-97F2-4FC5-B5D4-DC30D1CA1CBF @default.
- Q66042721 P4844 Q66042721-825FA839-9009-4475-97AB-41D67312BBCC @default.
- Q66042721 P580 Q66042721-C0B5DC75-7CDE-4948-B03B-95F06ADFFB1A @default.
- Q66042721 P582 Q66042721-D5916545-0A5E-4D7F-874F-86B4B8D153A0 @default.
- Q66042721 P6099 Q66042721-DE7FB035-1A39-41DA-8409-61592D9E9505 @default.
- Q66042721 P8363 Q66042721-DF5C716D-4BC4-471C-92B6-C30211B0CA11 @default.
- Q66042721 P1132 "+990" @default.
- Q66042721 P1476 "A 24-week, Double Blind, Double Dummy, Randomized, Multinational, Multicentre, 2-arm Parallel Group,Active Controlled Clinical Trial of Fixed Combination of Beclometasone Dipropionate Plus Formoterol Fumarate Plus Glycopyrronium Bromide Administered Via pMDI (CHF 5993) Versus the Fixed Combination of Budesonide Plus Formoterol Fumarate (Symbicort® Turbuhaler®) in Patients With Chronic Obstructive Pulmonary Disease" @default.
- Q66042721 P17 Q865 @default.
- Q66042721 P1813 "TRIVERSYTI" @default.
- Q66042721 P2899 "+40" @default.
- Q66042721 P3098 "NCT03197818" @default.
- Q66042721 P31 Q30612 @default.
- Q66042721 P4844 Q27132391 @default.
- Q66042721 P4844 Q411917 @default.
- Q66042721 P4844 Q422212 @default.
- Q66042721 P580 "2016-12-13T00:00:00Z" @default.
- Q66042721 P582 "2019-09-30T00:00:00Z" @default.
- Q66042721 P6099 Q42824827 @default.
- Q66042721 P8363 Q78089383 @default.